News
Brand Change Announcement: AegirBio AB has officially changed its name to Magnasense AB. The new website, www.magnasense.com, launched on 9 July 2024, with redirects from www.aegirbio.com.
Magnasense today announced the appointment of Vicki Johnson as interim Chief Financial Officer (CFO), succeeding Christel Dahlberg, who has resigned today due to private health reasons.
Vicki Johnson brings extensive experience in finance to her new role. She holds a Master's Degree in Chemistry from Oxford University and began her career at EY LLP, where she qualified as a Chartered Accountant (CA). Vicki has held various finance roles across professional services, manufacturing, and technology sectors, with expertise in financial reporting, audit, budgeting, forecasting, tax, and treasury.
For the past five years, Vicki Johnson has been a financial consultant with CFPro Limited (now part of BKL) in the UK, providing CFO services to a FTSE AIM-listed manufacturing company and a privately owned technology company.
"We are grateful to Christel Dahlberg for her contributions to Magnasense and wish her the best," said CEO Marco Witteveen. "We are confident that Vicki Johnson's leadership will guide Magnasense through this transition and advance our financial strategy."
"I am honored to step into the role of interim CFO at Magnasense," said Vicki Johnson. "I look forward to working with the executive team to drive our strategic goals and contribute to our future success."
Vicki Johnson has been appointed interim CFO starting immediately, while the recruitment of a new CFO is ongoing. The board and executive team are committed to ensuring a smooth transition and continued excellence in financial management.